Sunday, September 27, 2026

Bionano Genomics Stock Was 9.76% Up Today

NASDAQ Composite ended the session with Bionano Genomics rising 9.76% to $5.91 on Wednesday while nASDAQ Composite rose 1.19% to $13,950.22.

Bionano Genomics today's close was $5.91, 165.48% under its 52-week high of $15.69.

Bionano Genomics's Sales

Bionano Genomics's sales growth is 154.4% for the ongoing quarter and 203.7% for the next. The company's growth estimates for the ongoing quarter and the next is 86.7% and 44.4%, respectively.

Bionano Genomics's Revenue

Year-on-year quarterly revenue growth grew by 43%, now sitting on 8.5M for the twelve trailing months.

Volatility

Bionano Genomics's last day, last week, and last month's current volatility was 2.09%, 5.97%, and 5.11%, respectively.

Bionano Genomics's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 18.32% (day), 11.10% (last week), and 9.12% (last month), respectively.

Bionano Genomics's Stock Yearly Top and Bottom Value

Bionano Genomics's stock is valued at $5.91 at 17:23 EST, way under its 52-week high of $15.69 and way higher than its 52-week low of $0.28.

Bionano Genomics's Moving Average

Bionano Genomics's value is way under its 50-day moving average of $9.47 and way higher than its 200-day moving average of $4.64.

More news about Bionano Genomics.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Vertical AI Agents Attract a Funding Wave Across Fintech-Adjacent Industries
A cluster of AI-native startups applying autonomous agents to narrow, operational problems — hotel front-desk staffing (Dextr AI), identity/fraud risk for financial institutions (Baselayer), insurance distribution (Napo, Connie Health, MGT Insurance) — closed seed-to-Series A rounds within days of each other in September 2026, with CB Insights running a coordinated CEO interview series to spotlight them. The pattern points to agentic AI maturing from generic chat tools into vertical, revenue-generating products, with identity verification for AI agents themselves (Baselayer) emerging as a new fintech infrastructure category responding directly to AI-driven fraud risk.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com